학술논문

30 Long-term efficacy, safety, and predictors of response to amivantamab among patients with post-platinum EGFR Ex20ins-mutated advanced NSCLC
Document Type
Abstract
Source
In Journal of Thoracic Oncology April 2023 18(4) Supplement:S36-S37
Subject
Language
ISSN
1556-0864